BioCentury
ARTICLE | Preclinical News

Cambridge team identifies targets specific for squamous lung cancer

August 22, 2018 6:35 PM UTC

Researchers at University of Cambridge and colleagues identified an oncogene and epigenetic factors it regulates in lung squamous cell carcinoma (SCC), which could lead to new therapeutic targets for the indication.

The targeted therapy landscape for lung SCC is sparse, and the indication lags behind lung adenocarcinoma in therapeutic targets, even though both represent the most common forms of non-small cell lung cancer (NSCLC)...